|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2005-11-29
|
|
pubmed:abstractText |
Approximately 20-50% of IgA nephropathy patients develop end-stage renal disease. We have previously found enhanced oxidative stress and decreased antioxidant capacity in red blood cells of IgA nephropathy patients. In this study we assess oxidative stress, non-enzymatic glycation, oxidative resistance of low-density lipoprotein and its alpha-tocopherol content in these patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0301-0430
|
|
pubmed:author |
pubmed-author:BallaJJ,
pubmed-author:BalloUU,
pubmed-author:HeidlandAA,
pubmed-author:JeneiVV,
pubmed-author:KovácsTT,
pubmed-author:NagyJJ,
pubmed-author:SchinzelRR,
pubmed-author:VargaZZ,
pubmed-author:VasTT,
pubmed-author:WagnerZZ,
pubmed-author:WittmannII
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
343-51
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16312261-Adult,
pubmed-meshheading:16312261-Female,
pubmed-meshheading:16312261-Glomerulonephritis, IGA,
pubmed-meshheading:16312261-Glycosylation,
pubmed-meshheading:16312261-Glycosylation End Products, Advanced,
pubmed-meshheading:16312261-Humans,
pubmed-meshheading:16312261-Lipoproteins, LDL,
pubmed-meshheading:16312261-Male,
pubmed-meshheading:16312261-Middle Aged,
pubmed-meshheading:16312261-Oxidative Stress,
pubmed-meshheading:16312261-alpha-Tocopherol
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Oxidative stress and non-enzymatic glycation in IgA nephropathy.
|
|
pubmed:affiliation |
Second Department of Internal Medicine and Nephrological Center, Faculty of Medicine, University of Pécs, Pécs, Hungary.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
